What is MapLight Therapeutics, Inc. 's debt-to-equity?

MapLight Therapeutics, Inc. (MPLT) reported debt-to-equity of 0× in Q1 2026.

What does debt-to-equity mean?

Total debt (including capitalized leases and financing obligations) divided by shareholders' equity at the quarter end. Measures how much the company is financed by debt relative to equity.

MapLight Therapeutics, Inc. MPLT Debt-to-equity

Debt-to-equity at other companies

Bristol-Myers SquibbBMY

2.2×-0.6×

Johnson & JohnsonJNJ

0.7×0.0×

Neurocrine BiosciencesNBIX

0.1×-0.1×

Acadia PharmaceuticalsACAD

0×0.0×

AbbVieABBV

46.6×+38.6×

LBR

LB Pharmaceuticals Inc Common StockLBRX

0×—

Other financials

Income statement

See full

Operating income-$64.5M-174%

Net income-$60.7M-172%

EPS (diluted)-$1.34+95.4%

Balance sheet

See full

Cash & equivalents$55.7M—

Total debt$5.6M—

Total equity$399.8M+285%

Total assets$418.8M—

Cash flow

See full

Operating cash flow-$51.2M-100%

CapEx$24.0K—

Free cash flow-$51.2M—

Valuation

See full

Market cap$1.39B—

Enterprise value$1.34B—

Returns & leverage

See full

Return on equity-216.8%—

Current ratio22.9×—

Where this comes from

Calculated from MapLight Therapeutics, Inc. ’s reported figures.

total debt/total stockholders equity=0×

Based on the most recent quarter.

The official record: MapLight Therapeutics, Inc. ’s 10-Q, filed May 14, 2026, on SEC EDGAR. View the filing →

Ask your AI about MapLight Therapeutics, Inc. 's debt-to-equity.

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI

Claude

Questions, answered.

What is MapLight Therapeutics, Inc. 's debt-to-equity?: MapLight Therapeutics, Inc. (MPLT) reported debt-to-equity of 0× in Q1 2026.
What does debt-to-equity mean?: Total debt (including capitalized leases and financing obligations) divided by shareholders' equity at the quarter end. Measures how much the company is financed by debt relative to equity.